FindTrial
Sign In

Suprascapular Nerve Block: A Promising Addition to Corticosteroid Injection for Adhesive Capsulitis Management

ROLE OF SUPRASCAPULAR NERVE BLOCK IN ADDITION TO INTRA-ARTICULAR CORTICOSTEROID INJECTION ON PAIN AND RANGE OF MOTION IN PATIENTS WITH ADHESIVE CAPSULITIS OF SHOULDER JOINT - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095823
Enrollment
56
Registered
2025-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Intra-articular injection at glenohumeral joint (GHJ): Ultrasonography guided Intra-articular injection to GHJ with Methylprednisolone (MP) 60mg+ 1.5ml Normal Saline (Total drug volume

Sponsors

R. G. Kar Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients with history of adhesive capsulitis of shoulder joint -AMERICAN SOCIETY OF ANAESTHESIOLOGIST GRADING status I or II -Patients above 45 years and below 75 years of age -Patients who gave written informed consent to be the part of the study

Exclusion criteria

Exclusion criteria: -Patients who refused to give consent -ASA grade III or above -Severe pain at rest, history of trauma, systemic inflammatory disease, history of rotator cuff tear, radiological evidence of osteoarthritis of glenohumeral joint or any fracture -Patients with allergy to local anesthetic agents and Corticosteroids -Pregnancy, neoplasm, surgery to the shoulder in last 12 months -Likely not to comply with follow up -Uncontrolled systemic disorder, Bleeding disorder, Alcoholism

Design outcomes

Primary

MeasureTime frame
It is expected that when SSNB will be given along with intra-articular corticosteroid injection to GHJ in patients suffering from adhesive capsulitis of shoulder joint, it will more effectively reduce pain, improve the range of motion of shoulder.Timepoint: It is expected that when SSNB will be given along with intra-articular corticosteroid injection to GHJ in patients suffering from adhesive capsulitis of shoulder joint, it will more effectively reduce pain, improve the range of motion of shoulder.—

Secondary

MeasureTime frame
The patients who will be undergone SSNB+ IA Corticosteroid injection to GHJ are expected to have reduction in analgesics intake and increased Range Of Motion of shoulder jointTimepoint:—

Countries

India

Contacts

Public ContactATRIJIT KUMAR SAHA

R. G. Kar Medical College and Hospital, Kolkata

aratisahax@gmail.com9830438434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026